How HLA Genes Shape Type 1 Diabetes Risk—and When Other Autoimmune Diseases Appear Together
A new study from Croatia reveals that specific genetic markers called HLA class II alleles strongly influence who develops Type 1 diabetes and whether they'll also develop conditions like thyroid disease or celiac disease.
Evidence label explains the kind of source behind this article (for example peer-reviewed literature vs community video). It is not medical advice.
Key takeaways
- Type 1 diabetes is closely linked to specific HLA genes, particularly HLA-DRB1*03 and HLA-DRB1*04 variants and their haplotypes (gene combinations).
- About 37% of Type 1 diabetes patients in this study had a second autoimmune disease, most often affecting the thyroid.
- Different HLA patterns appear to influence which autoimmune diseases are more likely to occur alongside Type 1 diabetes.
- This research adds to our understanding of why some people develop Type 1 diabetes and helps explain the genetic foundations of autoimmune disease clustering.
- HLA testing cannot predict who will develop Type 1 diabetes on its own, but these genetic markers are part of the larger picture of disease risk.
The Genetic Foundation of Type 1 Diabetes
Type 1 diabetes is an autoimmune disease, meaning the immune system mistakenly attacks the insulin-producing cells in the pancreas. Unlike Type 2 diabetes, which is primarily linked to lifestyle factors, Type 1 has a strong genetic component. A major piece of this genetic puzzle involves genes called HLA class II genes, which help the immune system recognize what belongs in the body and what doesn't.
Researchers have long known that certain HLA gene variants are more common in people with Type 1 diabetes than in the general population. A new study from Eastern Croatia provides fresh evidence about which specific HLA variants and combinations matter most.
What the Study Found
Researchers examined 149 patients with Type 1 diabetes and compared their HLA genes to a control group of 111 unrelated blood donors from the same region. They focused on three HLA loci: HLA-DRB1, HLA-DQA1, and HLA-DQB1.
Two genetic patterns showed particularly strong associations with Type 1 diabetes. The HLA-DRB1*03 allele and the three-gene combination HLA-DQA1*05-DQB1*02-DRB1*03 (called the DR3-DQ2 haplotype) were both significantly more common in people with Type 1 diabetes than in the control group. Similarly, the HLA-DRB1*04 variant and the DR4-DQ8 haplotype also showed strong associations with Type 1 diabetes.
When Type 1 Diabetes Comes with Other Autoimmune Diseases
One striking finding was that more than one-third of the Type 1 diabetes patients in the study—about 37%—had developed at least one additional autoimmune disease. The most common was thyroid disease, affecting nearly a quarter of all patients. Other conditions included gastrointestinal problems like celiac disease (7.4%) and skin conditions (6.0%).
This clustering of autoimmune diseases is not random. The researchers found that certain HLA patterns were associated with specific combinations of diseases, suggesting that the same genetic factors that increase Type 1 diabetes risk can also influence the likelihood of other autoimmune conditions developing alongside it. Understanding these connections may eventually help doctors identify which patients are at higher risk for developing multiple autoimmune diseases.
What This Means for the Type 1 Diabetes Community
This study adds to a growing body of evidence showing that HLA genes are a crucial part of Type 1 diabetes development. However, it's important to understand what this research does and does not tell us. While certain HLA variants significantly increase the risk of Type 1 diabetes, they are not destiny. Many people carry these genetic markers without ever developing the disease, and genetic factors alone cannot predict who will get Type 1 diabetes.
For patients and families already living with Type 1 diabetes, this research underscores the importance of screening for other autoimmune conditions. If you have Type 1 diabetes, talking with your healthcare provider about whether screening for thyroid disease or celiac disease makes sense for you or your children is a practical next step.
Evidence label
Source: Frontiers in endocrinology. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.
Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.
Related reading
More evidence-labeled coverage across the Type1Cure library.
- Causes & What We KnowUnderstanding Type 1 Diabetes: A Shift Toward Early InterventionPubMed indexed literature
- Causes & What We KnowHow Nutrition, Metabolism, and Immunity Connect: What the Lectin Pathway Tells UsPubMed indexed literature
- Causes & What We KnowA Rare Skin Condition in Young Children with Type 1 Diabetes: What Parents Should KnowPubMed indexed literature
- Causes & What We KnowClinical modifiers of the association between type 1 diabetes and dementia incidence.PubMed indexed literature
- Causes & What We KnowNew Study Finds Genetic Links Between Type 1 Diabetes and Acute PancreatitisPubMed indexed literature
- Causes & What We KnowWhat Type 1 Diabetes and Alzheimer's Disease Have in CommonPubMed indexed literature